A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Clinical trial NCT05076617 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05076617
- Sponsor
- UCB Biopharma SRL
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2028-11-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.